Skip to main content
NEXTBIOMEDICAL Co., Ltd. logo

NEXTBIOMEDICAL Co., Ltd. — Investor Relations & Filings

Ticker · 389650 ISIN · KR7389650003 KO Manufacturing
Open in API
Filings indexed 56 across all filing types
Latest filing 2025-08-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 389650

About NEXTBIOMEDICAL Co., Ltd.

https://nextbiomedical.co.kr/en/

NEXTBIOMEDICAL Co., Ltd. is a company specializing in the development and commercialization of innovative therapeutic solutions, with a focus on drug-device combination products. The company's core competency is its proprietary polymer technology platform, which includes biodegradable adhesive polymers and resorbable microspheres. These technologies are applied to create first-in-class medical devices that address unmet clinical needs. Key product applications include advanced hemostatic agents for endoscopic procedures and embolic materials for interventional pain management and vascular therapies, such as genicular artery embolization for osteoarthritis pain.

Recent filings

Filing Released Lang Actions
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-annual Report) for the company 'NextBioMedical'. It covers the period from January 1, 2025, to June 30, 2025. It contains detailed financial information, business descriptions, management discussions, and corporate governance details, which are characteristic of an interim/quarterly report. It is not a mere announcement (RPA) or a certification, as it contains substantive financial and operational data. H1 2025
2025-08-14 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'NextBioMedical Co., Ltd.' covering the period from January 1, 2025, to March 31, 2025. It contains detailed financial and business information, including company overview, management, and business operations. This fits the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and their special relations (e.g., changes in special relations, stock option grants). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides the official outcomes of the shareholder meeting held on 2025-03-24, including the approval of financial statements, election of directors, and other resolutions. This falls directly under the category of Declaration of Voting Results & Voting Rights Announcements.
2025-03-24 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) submitted to the Korea Exchange (KRX). It provides the audit opinion (which is 'unqualified' or '적정'), key financial data, and details regarding capital impairment and loss ratios. While it contains financial data, it is a standardized regulatory disclosure form used to announce the receipt and submission of the audit report, rather than the full audit report document itself. Therefore, it fits the 'Audit Report / Information' category as it provides the essential audit findings and financial summary. FY 2024
2025-03-13 Korean
사업보고서 (2024.12)
Annual Report Classification · 1% confidence The document is a 'Business Report' (사업보고서) for the 11th fiscal year (2024) of NextBioMedical. It contains comprehensive company information, including business overview, management, capital structure, and detailed operational history. This is a standard annual regulatory filing required by the Financial Supervisory Service (FSS) and the Korea Exchange (KRX) in South Korea, which corresponds to the 10-K filing category in the provided schema. FY 2024
2025-03-13 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.